×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
Brittany Henderson

Brittany Henderson

Director, Senior Research Analyst for Health Care
15 Years experience
3 Years at firm

Brittany is a Senior Research Analyst for Health Care at ClearBridge Investments. She joined ClearBridge in 2022 and has 15 years of investment industry experience.

Prior to joining ClearBridge, Brittany worked at JP Morgan Asset Management as a Research Analyst focused on core equity, medical supplies & devices, and life science tools. Previously, she was a Research Analyst at Evercore ISI, focused on medical supplies & devices. Brittany started her career at Deutsche Bank Securities as an Investment Banking Analyst, before moving into a Research Analyst role, covering medical supplies & devices.

Brittany received a B.A. in English from Spelman College.

Brittany’s key ESG considerations in the health care sector include addressing unmet medical needs; governance (especially capital allocation and executive compensation); enabling research and products that improve health care outcomes; medical devices safety and efficacy; ethical sales and marketing practices; enabling diverse representation in clinical trials; humane treatment of animals used in clinical research and testing; medical devices pricing and access.

Experience

  • 15 years of investment industry experience
  • Joined ClearBridge Investments in 2022
  • JP Morgan Asset Management – Research Analyst, Core Equity, Medical Supplies & Devices, Life Science Tools
  • Evercore ISI – Research Analyst, Medical Supplies & Devices
  • Deutsche Bank Securities – Research Analyst, Medical Supplies & Devices
  • Deutsche Bank Securities – Investment Banking Analyst
  • B.A. in English from Spelman College

Perspectives

  • Health Care Innovation Under Trump 2.0
    Health care analysts assess the prospects for clinical breakthroughs in biopharmaceuticals and medical devices under a new administration.
  • AI Sustainability Opportunities and Risks
    ESG Investment 1Q24: As AI develops and hits multiple inflexion points over the next few years, companies across ClearBridge portfolios will need to negotiate a variety of sustainability-related AI opportunities and risks.
  • The Diabetes and Obesity Market Opportunity
    Analysts Marshall Gordon and Brittany Henderson discuss the leading pharmaceuticals and medical devices available for addressing these chronic conditions.
MORE